Page 406 - Traité de chimie thérapeutique 6 Médicaments antitumoraux
P. 406
362 MEDICAMENTINDUISANTOUSTABILISANTDES COUPURES DE L'ADN
PERSPECTIVES
NK-611, Drugs of Future, 1991, 16, 113-118.
SOLARY E., LETEURTRE F., PAULL K.D. SCUDIERO D., HAMEL E., POMMIER Y., Dual
inhibition of topoisornerase Il and tubulin polyrnerisation by azatoxin, a novel cytotoxic
agent, Biochem. Pharm., 1993, 45, 2449-2456.
LETEURTRE F., MADALENGOITIA J., ORR A., CUZI T.J., LEHNERT E., MCDONALD T.,
POMMIER Y., Rational design and rnolecular effects of a new topoisornerase Il inhi-
bitor, azatoxin, Cancer Research, 1992, 52, 4478-4483.
NK-611, Drugs of Future, 1995, 20, 205.
NK-611, Drugs of Future, 1996, 21, 213-214.
TOP-53, Drugs of Future, 1996, 21, 1136-1139.
TOP-53, Drugs of Future, 1999, 24, 1289.
NK-611, Drugs of Future, 2000, 25, 219.
TOP-53, Drugs of Future, 2001, 26, 1130-1131.
